

LONDON (Alliance News) - Oxford Pharmascience Group PLC said Monday that it had seen positive results from a pilot clinical study of its reduced gastr...


LONDON (Alliance News) - Oxford Pharmascience Group PLC said Wednesday it has appointed Quotient Clinical to undertake its early clinical development ...


Micky Arison, the long-standing Chairman of cruise line operator Carnival Corp., docked a batch of shares earlier this week ahead of its better-than-e...


LONDON (Alliance News) - Oxford Pharmascience Group PLC Wednesday said Non-Executive Chairman David Norwood bought 1 million shares at a price of 4.3 ...


LONDON (Alliance News) - Oxford Pharmascience Group PLC said Monday it has appointed a Director of research and development to manage the firms' devel...


LONDON (Alliance News) - Oxford Pharmascience Group PLC Monday said it has begun dosing subjects in the pilot clinical study of its OXP001 400 milligr...


LONDON (Alliance News) - Oxford Pharmascience Group PLC Wednesday said it appointed a new chief executive and saw a widened pretax loss in 2013 due to...


LONDON (Alliance News) - Oxford Pharmascience Group PLC Friday said its clinical trial application for OXP001 400 milogram reduced gastric irritation ...